Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04421820
Title BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bold Therapeutics, Inc.
Indications

colorectal cancer

stomach cancer

cholangiocarcinoma

pancreatic cancer

gastrointestinal system cancer

Therapies

BOLD-100 + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.